Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT03962725
PHASE4

Avoiding Neuromuscular Blockers to Reduce Complications

Sponsor: Beth Israel Deaconess Medical Center

View on ClinicalTrials.gov

Summary

The goal of this study to evaluate whether eliminating the use of non-depolarizing neuromuscular blocking agents (NMBA) for maintenance of general anesthesia reduces postoperative pulmonary complications in higher risk patients.

Official title: Eliminating Use of Non Depolarizing Neuromuscular Blocking Agents to Reduce Postoperative Pulmonary Complications: A Multi-center, Randomized Control Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

3

Start Date

2019-08-07

Completion Date

2022-12-19

Last Updated

2026-06-04

Healthy Volunteers

No

Interventions

DRUG

Neuromuscular Blocking Agents

Use of non depolarizing neuromuscular blocking agents for maintenance of general anesthesia.

DRUG

Anesthetic Adjuncts

Use of deeper plane of inhaled anesthetics or adjuncts (opioids, propofol, dexmedetomidine or ketamine for maintenance of general anesthesia.

Locations (2)

Massachusetts General Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States